[1]
Parra Serrano, G.A., Torres Langhammer, M.P., Pinto Arias, A.J. and Serrano-Gómez, S. 2022. Effectiveness of IDegLira in Type-2 Diabetes Patients During the COVID-19 Pandemic: A Teleconsultation Follow-up. Revista Colombiana de Endocrinología, Diabetes & Metabolismo. 9, 4 (Oct. 2022). DOI:https://doi.org/10.53853/encr.9.4.740.